More on INZY

- Summary
- Chart
- Profile
- Historical

Data

- Ratings (10.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inozyme Pharma Inc. (NQ:INZY)
Delayed: 16.46 -2.74 (14.27%)
Prev. Close $19.20  
Open$19.06 
52 Wk High$ 
52 Wk Low$ 
Day High$19.06 
Day Low$16.10 
P/E N/A  
EPS$ 
Volume230,544 

Friends, Peers and Foes (?): AXNX, CMPI, PSTX, PCVX, MTEM (more...)

Jul 21, 2021 07:30 AM Inozyme Pharma Inc. (INZY) Receives Orphan Drug Designation for INZ-701 from the European Medicines Agency for the Treatment of ABCC6 Deficiency
Jul 21, 2021 07:30 AM Inozyme Pharma Receives Orphan Drug Designation for INZ-701 from the European Medicines Agency for the Treatment of ABCC6 Deficiency
Jul 13, 2021 07:30 AM Inozyme Pharma Announces Appointment of Gayle Gironda as Senior Vice President, Human Resources
Jun 25, 2021 07:58 AM Form 4 Inozyme Pharma, Inc. For: Jun 24 Filed by: Bolte Axel
Jun 25, 2021 07:49 AM Form 4 Inozyme Pharma, Inc. For: Jun 23 Filed by: Bhagat Sarah M
Jun 24, 2021 05:33 PM Form 4 Inozyme Pharma, Inc. For: Jun 23 Filed by: Mathers Edward T
Jun 24, 2021 04:17 PM Form 4 Inozyme Pharma, Inc. For: Jun 23 Filed by: Edwards Martin
Jun 24, 2021 04:16 PM Form 4 Inozyme Pharma, Inc. For: Jun 23 Filed by: Treco Douglas A
Jun 24, 2021 04:15 PM Form 4 Inozyme Pharma, Inc. For: Jun 23 Filed by: Sullivan Lynne Marie
Jun 24, 2021 04:13 PM Form 4 Inozyme Pharma, Inc. For: Jun 23 Filed by: Hopfner Robert Lorne
View All Articles

Entities mentioned with INZY

View All Entities